[Skip To Content]
[Website of the National Cancer Institute's Technology Transfer Center.  Partnering with Industry for Improved Public Health.]
  • Home
  • Collaborative Opportunities
  • Standard Forms and Agreements
  • Technology Transfer Training
  • Resources
  • Intellectual Property

Vaccines

Novel Therapeutics for the Treatment and Prevention of Avian Influenza
Background: The National Cancer Institute is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize cyanovirin-N for use against H5N1 influenza. The technology is also available (more...)
(Full Text)

Inactivation of Enveloped Viruses and Tumor Cells for Infectious Disease and Cancer Vaccines
Background: The Membrane Structure & Function Laboratory of the National Cancer Institute is seeking statements of capability or interest from parties interested in collaborative research to obtain pre-clinical data to be used to further develop, (more...)
(Full Text)

Novel Cancer Immunotherapy Approaches For The Treatment And Prevention Of Cancer
Background: The National Cancer Institute's Laboratory of Tumor Immunology and Biology is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize cancer immunotherapy using costimulation.  See (more...)
(Full Text)

Method To Inactivate Viruses For Vaccine Development
Background: The National Cancer Institute's Nanobiology Program is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize the use of hydrophobic crosslinkers for vaccine development using (more...)
(Full Text)


E-MAIL SERVICE

TTC maintains an e-mail service to notify you of new Collaborative Opportunities. If you would like to receive these emails, please sign up below. If you'd like to unsubscribe you can use this form as well.

Page Last Updated: 11-07-2008